TY - JOUR T1 - A phase 2, open鈥恖abel study of single鈥恉ose dupilumab in children aged 6聽months to <6聽years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy JO - Journal of the European Academy of Dermatology and Venereology UR - https://eprints.whiterose.ac.uk/177102/ PY - 2021/02/01 AU - Paller AS AU - Siegfried EC AU - Simpson EL AU - Cork MJ AU - Lockshin B AU - Kosloski MP AU - Kamal MA AU - Davis JD AU - Sun X AU - Pirozzi G AU - Graham NMH et al ED - DO - DOI: 10.1111/jdv.16928 PB - Wiley VL - 35 IS - 2 SP - 464 EP - 475 Y2 - 2025/06/29 ER -